Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/3/2022 | Outperform → Market Perform | William Blair | |
| 2/2/2022 | $16.00 → $6.00 | Hold | Chardan Capital |
| 12/23/2021 | $20.00 → $16.00 | Buy | Chardan Capital |
| 11/17/2021 | $24.00 → $8.00 | Overweight | Barclays |
| 11/16/2021 | $17.00 → $16.00 | Market Outperform | JMP Securities |
William Blair downgraded LogicBio Therapeutics from Outperform to Market Perform
Chardan Capital reiterated coverage of LogicBio Therapeutics with a rating of Hold and set a new price target of $6.00 from $16.00 previously
Chardan Capital reiterated coverage of LogicBio Therapeutics with a rating of Buy and set a new price target of $16.00 from $20.00 previously
OAKLAND, Calif., May 30, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC) ("ContextLogic," the "Company," "we" or "our") today announced its intention to voluntarily delist from The Nasdaq Global Market at the close of markets on June 2, 2025 and to begin trading on the OTCQB® Venture Market of the OTC Markets on June 3, 2025. The Company is pleased to announce that the Company has been accepted for listing on the OTCQB® Venture Market of the OTC Markets (the "OTC Markets") and that the Company's Class A Common Stock, par value $0.0001 per share (the "Common Stock") will commence trading on the OTC Markets on Tuesday, June 3, 2025 under the ticker symbol "LOGC". Shareholders will
OAKLAND, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the quarter ended March 31, 2025. First-Quarter 2025 Financial Highlights Net Loss: Net loss was $4 million, compared to a net loss of $59 million in the first quarter of fiscal year 2024.As of March 31, 2025, the Company had $64 million in cash and cash equivalents, $158 million in marketable securities and $1 million in prepaid expenses and other current assets primarily made up of restricted cash. The Company had total liabilities of $3 million. ContextLogic will host a financial results conference call a
OAKLAND, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC), ("ContextLogic" or the "Company") today announced it will report its first quarter 2025 financial results after the close of market on Friday, May 9, 2025. ContextLogic's CEO Rishi Bajaj and its Chairman Ted Goldthorpe will host a live conference call and webcast for shareholders, analysts and portfolio managers that afternoon at 5:00 PM ET / 2:00 PM PT. Information about the Company's financial results, including a link to the live webcast and replay will be made available on the Company's investor relations website at https://ir.contextlogicinc.com. The live conference call may be accessed by registering
SC 13G/A - ContextLogic Inc. (0001822250) (Subject)
SC 13G/A - LogicBio Therapeutics, Inc. (0001664106) (Subject)
SC 13D/A - LogicBio Therapeutics, Inc. (0001664106) (Subject)